Cargando…
Carbonic Anhydrase XII is a Clinically Significant, Molecular Tumor-Subtype Specific Therapeutic Target in Glioma with the Potential to Combat Invasion of Brain Tumor Cells
BACKGROUND: The metabolic enzyme carbonic anhydrase 12 (CA12/CAXII) emerges as a promising cancer therapeutic target with drug development projects underway. Previous reports proposed the relevance of CA12 in the context of glioma but are limited in patient data quantity, ignore ethnic diversity of...
Autores principales: | Li, Guanzhang, Chen, Ting-Wei, Nickel, Ann-Christin, Muhammad, Sajjad, Steiger, Hans-Jakob, Tzaridis, Theophilos, Hänggi, Daniel, Zeidler, Reinhard, Zhang, Wei, Kahlert, Ulf Dietrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939492/ https://www.ncbi.nlm.nih.gov/pubmed/33692626 http://dx.doi.org/10.2147/OTT.S300623 |
Ejemplares similares
-
Rapalink-1 Targets Glioblastoma Stem Cells and Acts Synergistically with Tumor Treating Fields to Reduce Resistance against Temozolomide
por: Vargas-Toscano, Andres, et al.
Publicado: (2020) -
Different Calculation Strategies Are Congruent in Determining Chemotherapy Resistance of Brain Tumors In Vitro
por: Fischer, Igor, et al.
Publicado: (2020) -
An inexpensive and easy-to-implement approach to a Quality Management System for an academic research lab
por: Hewera, Michael, et al.
Publicado: (2020) -
First studies on tumor associated carbonic anhydrases IX and XII monoclonal antibodies conjugated to small molecule inhibitors
por: Testa, Chiara, et al.
Publicado: (2022) -
Carbonic anhydrase XII as biomarker and therapeutic target in ovarian carcinomas
por: Hiepp, Lisa, et al.
Publicado: (2022)